Acceleron Pharma Inc.
Combined use of GDF traps and erythropoietin receptor activators to increase red blood cell levels

Last updated:

Abstract:

In certain aspects, the present invention provides compositions and methods for increasing red blood cell and/or hemoglobin levels in vertebrates, including rodents and primates, and particularly in humans.

Status:
Grant
Type:

Utility

Filling date:

11 Oct 2018

Issue date:

23 Jun 2020